Targeted Drug-delivery Approaches By Nanoparticulate Carriers In The Therapy Of Inflammatory Diseases
Main Category: Arthritis / RheumatologyAlso Included In: Multiple Sclerosis
Article Date: 30 Nov 2009 - 0:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
3 (4 votes) |
| Healthcare Prof: |  |
5 (2 votes) |
| Article Opinions: | 1 posts |
Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases.
The therapeutic drawback can be overcome using nanocarrier-based drug targeting strategies which improve the selective delivery of drugs to the site of action, the so called drug targeting.
Specific uptake of nanoparticles by immune related cells in inflamed barriers offers selective drug targeting to the inflamed tissue. Common inflammatory disorders like rheumatoid arthritis, multiple sclerosis, uveitis or inflammatory bowel disease can be efficiently treated using nanocarrier-based drug delivery strategies which avoid common adverse effects.
Source
Journal of the Royal Society Interface
Visit our arthritis / rheumatology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/172396.php>
APA
http://www.medicalnewstoday.com/releases/172396.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Drug-delivery AND Rheumatoid Arthritis
posted by farzaneh on 25 Aug 2010 at 12:29 amfor tissue engineering
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
